Company Overview
- Headquarters
- 7000 Shoreline Court Suite 201, South San Francisco CA
- Website
- tricida.com
- Phone
- (415) 429-7800
- Employees
- 32
- Founded in
- 2013
- Industry
- Materials/Manufacturing
- Stock Symbol
- NASDAQ:TCD
- NAICS Code
-
NAICS Code 6215 CompaniesNAICS Code 62151 CompaniesNAICS Code 32 CompaniesNAICS Code 3254 CompaniesNAICS Code 32541 CompaniesNAICS Code 325 CompaniesNAICS Code 62 CompaniesNAICS Code 621 Companies
- SIC Code
-
SIC Code 283 CompaniesSIC Code 28 Companies
Financials & Stats
Revenue
$19B
Total Funding Amount
$1M
Who is Tricida
Tricida, Inc. is a pharmaceutical company headquartered in South San Francisco, California. The company employs 32 people and has generated $19.2 million in revenue. Tricida focuses on developing and commercializing veverimer (TRC101), a novel drug designed to treat metabolic acidosis associated with chronic kidney disease (CKD). This non-absorbed, oral polymer is targeted at patients suffering from the condition, which is often a complication of CKD and can contribute to disease progression, muscle loss, and bone density reduction. The company was established in August 2013 by a team with extensive experience in developing and commercializing therapeutics. Their expertise extends to the field of polymers used in treating kidney-related diseases. Customers interested in learning more about Tricida and veverimer can visit their website at tricida.com.
Company Leadership
Tricida Industry Tags
Tricida Tech Stack
Companies Similar to Tricida
Analyze industry trends and opportunities by examining competitors and companies comparable to Tricida, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 19M | 169 | Brentwood, TN | 2019 | |
| 19M | 109 | Elgin, IL | 1987 | |
| 19M | 30 | Buena Park, CA | 1998 | |
| 19M | 48 | Santa Ana, CA | 1972 | |
| 19M | 33 | Davenport, IA | 1991 |